ACHN Shares Outstanding History
Below is a table of the ACHN shares outstanding history going back to 3/9/2010:

Date ACHN Shares Outstanding
3/9/201038.52M
5/7/201038.52M
10/25/201058.35M
3/1/201158.39M
5/1/201158.41M
8/1/201169.72M
11/1/201169.74M
3/1/201270.57M
5/1/201270.65M
8/1/201272.53M
11/1/201279.52M
2/11/201379.65M
5/1/201396.56M
8/1/201396.64M
11/1/201396.68M
3/3/201496.79M
5/1/201496.80M
8/1/201497.79M
11/1/2014100.25M
3/1/2015117.54M
5/1/2015117.56M
8/1/2015136.39M
11/1/2015136.54M
2/19/2016136.64M
5/1/2016136.64M
8/1/2016136.68M
11/1/2016136.68M
2/20/2017136.72M
5/1/2017136.72M
8/1/2017136.76M
10/27/2017136.86M
2/20/2018137.89M
5/1/2018138.34M
8/1/2018138.59M
11/1/2018138.62M

Also see: ACHN Market Cap History
and ACHN YTD Return
ACHN Historical Shares Outstanding:
+15.95% CAGR
ACHN Historical Shares Outstanding: +15.95% CAGR

Mouse over chart for data details
3/9/2010 ...11/1/2018
Achillion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery and development of small molecule drug therapies for infectious diseases and immune system disorders. Co.'s focus is on its complement inhibitor platform, directed at developing small molecule compounds to be used in the treatment of immune-related diseases. The alternative pathway plays a role in a number of disease conditions including rare orphan conditions such as paroxysmal nocturnal hemoglobinuria, a blood disorder, C3 glomerulopathy and immune complex membranoproliferative glomerulonephritis, both kidney diseases, as well as several more prevalent indications. We show 35 historical shares outstanding datapoints in our coverage of ACHN's shares outstanding history.

Understanding the changing numbers of ACHN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ACHN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ACHN by allowing them to research ACHN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ACHN:
ACHN SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Achillion Pharmaceuticals (ACHN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ACHV Shares Outstanding History
ACOR Shares Outstanding History
ACRS Shares Outstanding History
ACRX Shares Outstanding History
ACST Shares Outstanding History
ADMA Shares Outstanding History
ADMP Shares Outstanding History
ADMS Shares Outstanding History
ADRO Shares Outstanding History
ADUS Shares Outstanding History
More Healthcare companies »

 

ACHN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2018, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.